News Release

Media Contact

Kristin Bhavnani
Head of Global Corporate Communications
Jazz Pharmaceuticals plc

Send Email
Ireland: +353 1 637 2141
US: 215-867-4948

Jazz Pharmaceuticals Announces Presentations at Investor Conferences in November

November 09, 2011

PALO ALTO, Calif., Nov. 9, 2011 /PRNewswire via COMTEX/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today announced that the company's management will present a business and financial update at the following upcoming conferences:

8th Annual Lazard Capital Markets Healthcare Conference

Tuesday, November 15, 2011

8:00 a.m. ET

New York, NY

23rd Annual Piper Jaffray Healthcare Conference

Wednesday, November 30, 2011

11:00 a.m. ET

New York, NY

A live webcast of each presentation may be accessed from the Investors section of the Jazz Pharmaceuticals website at http://www.jazzpharmaceuticals.com/. Please connect to the website prior to the start of the presentation to ensure adequate time for any software downloads that may be necessary to listen to the webcast.

Archived versions of the webcasts will be available for at least one week following each conference on the Investors section of the company's website at http://www.jazzpharmaceuticals.com/.

About Jazz Pharmaceuticals

Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet needs in neurology and psychiatry. For further information, see http://www.jazzpharmaceuticals.com/.

SOURCE Jazz Pharmaceuticals, Inc.